Please note: The information displayed on this page might be outdated.
NovaGo Therapeutics: NovaGo Therapeutics is a Swiss development stage biotech company focused on human antibody therapeutics targeting blood vessel and nerve growth.
Company Participants at European Biotech Investor Days 2021
NovaGo Therapeutics, CEO
Mr. Ian Metcalfe serves as Chief Executive Officer at NovaGo Therapeutics. Mr. Ian Metcalfe serves as Chief Executive Officer at NovaGo Therapeutics. Mr. Ian Metcalfe serves as Investor Relations Officer at Nestle. Ian has over 20 years of experience focused on healthcare and biotech. During his early career he successfully raised funds for the start-up Etna Biotech while managing the R&D communications and CSO office for Berna Biotech. Joining Roche in 2005 in Partnering, Ian then held various positions of increasing responsibility in Investor Relations and Global Product Strategy. In 2010 he moved to Nestlé in Investor Relations and in 2015 he became the lead for business development at Nestlé Health Science for Inborn Errors of Metabolism and Consumer Care products. Ian returned to Roche in 2017 as the late stage portfolio lead for partnering and business planning, alongside his role as Head of Basel Site for Portfolio and Product Development Strategy. Prior to joining NovaGo as CEO in 2020 Ian worked as Chief Operating Officer for Corlieve Therapeutics, a start-up biotech in Basel, Switzerland. Ian holds a 1st class degree in Applied biology (genetic engineering), and a Masters in Marketing from UMIST. Further studies include executive education programmes with Harvard Business School, INSEAD, IMD and Oxford University.